Predict your next investment

Venture Capital
ampappas.com

See what CB Insights has to offer

Investments

8

Portfolio Exits

1

Funds

1

About A.M. Pappas Life Science Ventures

A. M. Pappas & Associates is a venture capital firm. They are dedicated to the development of life science companies, products, technologies and ventures and other significant entrepreneurial opportunities.The firm is located in the Research Triangle area of North Carolina. Since 1994 we have been investing in and nurturing promising young companies, while delivering superior results to investors and entrepreneurs alike. The firm also has important philanthropic interests in support of the life sciences, public education and entrepreneurial endeavors.

A.M. Pappas Life Science Ventures Headquarter Location

2520 Meridian Parkway Suite 400

Durham, North Carolina, 27713,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

A.M. Pappas Life Science Ventures Investments

8 Investments

A.M. Pappas Life Science Ventures has made 8 investments. Their latest investment was in Artax Biopharma as part of their Series B on September 9, 2015.

CBI Logo

A.M. Pappas Life Science Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/22/2015

Series B

Artax Biopharma

$10M

No

2

11/10/2014

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/5/2009

Series B

Subscribe to see more

$99M

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Other Investors

Subscribe to see more

Subscribe to see more

0

Date

9/22/2015

11/10/2014

10/5/2009

Round

Series B

Series A

Series B

Other Investors

Other Investors

Company

Artax Biopharma

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$10M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

0

0

0

A.M. Pappas Life Science Ventures Portfolio Exits

1 Portfolio Exit

A.M. Pappas Life Science Ventures has 1 portfolio exit. Their latest portfolio exit was Cequent Pharmaceuticals on April 01, 2010.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/1/2010

Acquired

$99M

1

Date

4/1/2010

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

A.M. Pappas Life Science Ventures Fund History

1 Fund History

A.M. Pappas Life Science Ventures has 1 fund, including A. M. Pappas Life Science Ventures V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/15/2019

A. M. Pappas Life Science Ventures V

$85.75M

1

Closing Date

1/15/2019

Fund

A. M. Pappas Life Science Ventures V

Fund Type

Status

Amount

$85.75M

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.